Andrew H. Miller
#111,784
Most Influential Person Now
Andrew H. Miller's AcademicInfluence.com Rankings
Andrew H. Millerpsychology Degrees
Psychology
#2215
World Rank
#2585
Historical Rank
Clinical Psychology
#161
World Rank
#163
Historical Rank
Andrew H. Millerphilosophy Degrees
Philosophy
#4718
World Rank
#7338
Historical Rank
Logic
#2122
World Rank
#3043
Historical Rank
Download Badge
Psychology Philosophy
Andrew H. Miller's Degrees
- PhD Psychology Stanford University
- Doctorate Medicine Harvard University
Why Is Andrew H. Miller Influential?
(Suggest an Edit or Addition)Andrew H. Miller's Published Works
Published Works
- Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression (2009) (3107)
- Cytokines sing the blues: inflammation and the pathogenesis of depression. (2006) (2667)
- The role of inflammation in depression: from evolutionary imperative to modern treatment target (2015) (2054)
- The link between childhood trauma and depression: Insights from HPA axis studies in humans (2008) (1449)
- Chronic inflammation in the etiology of disease across the life span (2019) (1434)
- A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. (2013) (1260)
- Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment (2001) (1101)
- Mood Disorders in the Medically Ill: Scientific Review and Recommendations (2005) (1009)
- Immune system to brain signaling: neuropsychopharmacological implications. (2011) (909)
- The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine and immune interactions (1997) (834)
- Childhood trauma associated with smaller hippocampal volume in women with major depression. (2002) (789)
- Psychoneuroimmunology Meets Neuropsychopharmacology: Translational Implications of the Impact of Inflammation on Behavior (2012) (740)
- Neurobehavioral Effects of Interferon-α in Cancer Patients: Phenomenology and Paroxetine Responsiveness of Symptom Dimensions (2002) (714)
- When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. (2011) (687)
- Depressive disorders and immunity: 20 years of progress and discovery (2007) (624)
- When Not Enough Is Too Much: The Role of Insufficient Glucocorticoid Signaling in the Pathophysiology of Stress-Related Disorders (2003) (592)
- CYTOKINE TARGETS IN THE BRAIN: IMPACT ON NEUROTRANSMITTERS AND NEUROCIRCUITS (2013) (580)
- CSF Concentrations of Brain Tryptophan and Kynurenines during Immune Stimulation with IFN-alpha: Relationship to CNS Immune Responses and Depression (2009) (564)
- Cytokine-effects on glucocorticoid receptor function: Relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression (2007) (559)
- Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? (2003) (507)
- Cytokines and psychopathology: Lessons from interferon-α (2004) (486)
- Interferon-alpha–induced changes in tryptophan metabolism relationship to depression and paroxetine treatment (2003) (474)
- Altered Pituitary-Adrenal Axis Responses to Provocative Challenge Tests in Adult Survivors of Childhood Abuse (2001) (469)
- Is Depression an Inflammatory Disorder? (2011) (460)
- The role of early adverse experience and adulthood stress in the prediction of neuroendocrine stress reactivity in women: A multiple regression analysis (2002) (450)
- Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. (2006) (435)
- Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. (2008) (434)
- Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection. (2005) (426)
- Neuropsychiatric Adverse Effects of Interferon-α (2005) (395)
- Increased Stress-Induced Inflammatory Responses in Male Patients With Major Depression and Increased Early Life Stress (2006) (333)
- Activation of Central Nervous System Inflammatory Pathways by Interferon-Alpha: Relationship to Monoamines and Depression (2009) (324)
- Depression in cancer: new developments regarding diagnosis and treatment (2003) (319)
- Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction. (2005) (302)
- Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy. (2003) (295)
- Dopaminergic mechanisms of reduced basal ganglia responses to hedonic reward during interferon alfa administration. (2012) (288)
- Cytokines and Glucocorticoid Receptor Signaling (2009) (278)
- Cytokines and psychopathology: lessons from interferon-alpha. (2004) (275)
- A Cytokine-Based Neuroimmunologic Mechanism of Cancer-Related Symptoms (2004) (275)
- Depression and immunity: A role for T cells? (2010) (271)
- Neuropsychiatric adverse effects of interferon-alpha: recognition and management. (2005) (265)
- Cytokine effects on the basal ganglia and dopamine function: The subcortical source of inflammatory malaise (2012) (265)
- Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders (2017) (264)
- Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy (2004) (228)
- Mechanisms of cytokine-induced behavioral changes: Psychoneuroimmunology at the translational interface (2009) (219)
- What does plasma CRP tell us about peripheral and central inflammation in depression? (2018) (219)
- Anterior Cingulate Activation and Error Processing During Interferon-Alpha Treatment (2005) (216)
- Characterization of Early Cytokine Responses and an Interleukin (IL)-6–dependent Pathway of Endogenous Glucocorticoid Induction during Murine Cytomegalovirus Infection (1997) (215)
- Eating ourselves to death (and despair): The contribution of adiposity and inflammation to depression (2010) (211)
- The Proinflammatory Cytokine, Interleukin-1α, Reduces Glucocorticoid Receptor Translocation and Function1. (1999) (201)
- Decreased heart rate variability is associated with higher levels of inflammation in middle-aged men. (2008) (193)
- Depressive Symptoms and Metabolic Syndrome: Is Inflammation the Underlying Link? (2008) (193)
- Basal Ganglia Hypermetabolism and Symptoms of Fatigue during Interferon-α Therapy (2007) (187)
- Pituitary-adrenal responses to standard and low-dose dexamethasone suppression tests in adult survivors of child abuse (2004) (186)
- Effects of Interferon-Alpha on Rhesus Monkeys: A Nonhuman Primate Model of Cytokine-Induced Depression (2007) (185)
- Corticosterone regulation of Type I and Type II adrenal steroid receptors in brain, pituitary, and immune tissue (1991) (171)
- Steroid-Independent Translocation of the Glucocorticoid Receptor by the Antidepressant Desipramine (1997) (166)
- Antidepressant treatment resistance is associated with increased inflammatory markers in patients with major depressive disorder (2018) (158)
- Breast cancer and depression. (2004) (152)
- Inhibition of the NF-κB signaling pathway by the curcumin analog, 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31): anti-inflammatory and anti-cancer properties. (2012) (151)
- Adrenal steroid receptor activation in rat brain and pituitary following dexamethasone: Implications for the dexamethasone suppression test (1992) (148)
- Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals? (2009) (144)
- Chronic Interferon-α Decreases Dopamine 2 Receptor Binding and Striatal Dopamine Release in Association with Anhedonia-Like Behavior in Nonhuman Primates (2013) (144)
- Tyrosine metabolism during interferon-alpha administration: Association with fatigue and CSF dopamine concentrations (2013) (139)
- Association of Major Depressive Disorder with Serum Myeloperoxidase and Other Markers of Inflammation: A Twin Study (2008) (132)
- Depressive symptoms and viral clearance in patients receiving interferon-α and ribavirin for hepatitis C (2005) (130)
- IFN-alpha-induced motor slowing is associated with increased depression and fatigue in patients with chronic hepatitis C (2008) (127)
- Treatment of cytokine-induced depression (2002) (124)
- Differential activation of adrenal steroid receptors in neural and immune tissues of Sprague Dawley, Fischer 344, and Lewis rats (1995) (121)
- Alterations in Diurnal Salivary Cortisol Rhythm in a Population-Based Sample of Cases With Chronic Fatigue Syndrome (2008) (121)
- IFN-Alpha-Induced Cortical and Subcortical Glutamate Changes Assessed by Magnetic Resonance Spectroscopy (2014) (118)
- Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy. (2007) (111)
- Adherence to the Mediterranean Diet Is Inversely Associated With Circulating Interleukin-6 Among Middle-Aged Men: A Twin Study (2008) (109)
- Therapeutic Implications of Brain–Immune Interactions: Treatment in Translation (2017) (104)
- Chronic Interferon-Alpha Administration Disrupts Sleep Continuity and Depth in Patients with Hepatitis C: Association with Fatigue, Motor Slowing, and Increased Evening Cortisol (2010) (103)
- Cognitive Dysfunction Relates to Subjective Report of Mental Fatigue in Patients with Chronic Fatigue Syndrome (2006) (98)
- Identification and treatment of symptoms associated with inflammation in medically ill patients (2008) (95)
- Inflammatory markers are associated with decreased psychomotor speed in patients with major depressive disorder (2016) (92)
- Antipsychotic-induced hyperprolactinemia and sexual dysfunction. (2002) (92)
- Inflammation Effects on Brain Glutamate in Depression: Mechanistic Considerations and Treatment Implications. (2017) (90)
- Are Anti-inflammatory Therapies Viable Treatments for Psychiatric Disorders?: Where the Rubber Meets the Road. (2015) (88)
- Common Genetic Contributions to Depressive Symptoms and Inflammatory Markers in Middle-Aged Men: The Twins Heart Study (2009) (87)
- Association between posttraumatic stress disorder and inflammation: A twin study (2013) (84)
- Early life stress and PTSD symptoms in patients with comorbid schizophrenia and substance abuse (2004) (82)
- Association of a Polymorphism in the Indoleamine-2,3-Dioxygenase Gene and Interferon-α-Induced Depression in Patients with Chronic Hepatitis C (2011) (79)
- Characterization of an interleukin-6- and adrenocorticotropin-dependent, immune-to-adrenal pathway during viral infection. (2004) (79)
- Associations among peripheral and central kynurenine pathway metabolites and inflammation in depression (2020) (79)
- Role of inflammation in depression: implications for phenomenology, pathophysiology and treatment. (2013) (76)
- Malaise, melancholia and madness: The evolutionary legacy of an inflammatory bias (2013) (76)
- Conceptual Confluence: The Kynurenine Pathway as a Common Target for Ketamine and the Convergence of the Inflammation and Glutamate Hypotheses of Depression (2013) (72)
- Beyond depression: the expanding role of inflammation in psychiatric disorders (2020) (71)
- TNF-α and IL-6 are associated with the deficit syndrome and negative symptoms in patients with chronic schizophrenia (2018) (69)
- Can’t or Won’t? Immunometabolic Constraints on Dopaminergic Drive (2019) (69)
- Impact of Ixekizumab Treatment on Depressive Symptoms and Systemic Inflammation in Patients with Moderate-to-Severe Psoriasis: An Integrated Analysis of Three Phase 3 Clinical Studies (2017) (69)
- Decreased Basal Ganglia Activation in Subjects with Chronic Fatigue Syndrome: Association with Symptoms of Fatigue (2014) (66)
- The neuroendocrine response to fenfluramine in depressives and normal controls (1988) (64)
- Serotonin Transporter Gene, Depressive Symptoms, and Interleukin-6 (2009) (62)
- Fatigue is associated with inflammation in patients with head and neck cancer before and after intensity-modulated radiation therapy (2016) (62)
- Increased inflammation and brain glutamate define a subtype of depression with decreased regional homogeneity, impaired network integrity, and anhedonia (2018) (61)
- Inflammation‐induced activation of the indoleamine 2,3‐dioxygenase pathway: Relevance to cancer‐related fatigue (2015) (61)
- Inhibition of tumor necrosis factor improves sleep continuity in patients with treatment resistant depression and high inflammation (2015) (60)
- Epigenetic changes associated with inflammation in breast cancer patients treated with chemotherapy (2014) (59)
- Neuropsychological Performance in Persons With Chronic Fatigue Syndrome: Results From a Population-Based Study (2008) (57)
- The Phosphodiesterase Type 4 Inhibitor, Rolipram, Enhances Glucocorticoid Receptor Function (2002) (57)
- Increased early life stress and depressive symptoms in patients with comorbid substance abuse and schizophrenia. (2002) (57)
- Inflammation and decreased functional connectivity in a widely-distributed network in depression: Centralized effects in the ventral medial prefrontal cortex (2019) (57)
- Neurobehavioral Effects of Interferon-α in Patients with Hepatitis-C: Symptom Dimensions and Responsiveness to Paroxetine (2012) (55)
- Inhibition of Jun N-Terminal Kinase (JNK) Enhances Glucocorticoid Receptor-Mediated Function in Mouse Hippocampal HT22 Cells (2005) (53)
- Association of childhood trauma with fatigue, depression, stress, and inflammation in breast cancer patients undergoing radiotherapy (2016) (52)
- Transcriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depression (2013) (52)
- Levodopa Reverses Cytokine-Induced Reductions in Striatal Dopamine Release (2015) (51)
- Age-related increases in basal ganglia glutamate are associated with TNF, reduced motivation and decreased psychomotor speed during IFN-alpha treatment: Preliminary findings (2015) (50)
- Massage therapy decreases cancer‐related fatigue: Results from a randomized early phase trial (2018) (48)
- Cerebrospinal Fluid Corticotropin-Releasing Factor (CRF) and Vasopressin Concentrations Predict Pituitary Response in the CRF Stimulation Test: A Multiple Regression Analysis (2003) (47)
- Meditation buffers medical student compassion from the deleterious effects of depression (2018) (47)
- A systematic review of the association between fatigue and genetic polymorphisms (2017) (46)
- Effects of viral infection on corticosterone secretion and glucocorticoid receptor binding in immune tissues (1997) (46)
- Do Cytokines Really Sing the Blues? (2013) (46)
- Genetic and environmental influences on systemic markers of inflammation in middle-aged male twins. (2008) (46)
- Association of IL-12p70 and IL-6:IL-10 ratio with autism-related behaviors in 22q11.2 deletion syndrome: A preliminary report (2013) (45)
- The Immunology of Behavior—Exploring the Role of the Immune System in Brain Health and Illness (2017) (43)
- Longitudinal association of inflammation with depressive symptoms: A 7-year cross-lagged twin difference study (2019) (42)
- Neonatal Viral Infection Decreases Neuronal Progenitors and Impairs Adult Neurogenesis in the Hippocampus (2002) (42)
- Pathogen–Host Defense in the Evolution of Depression: Insights into Epidemiology, Genetics, Bioregional Differences and Female Preponderance (2016) (42)
- Interferon-alpha inhibits glucocorticoid receptor-mediated gene transcription via STAT5 activation in mouse HT22 cells (2009) (41)
- Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis (2019) (41)
- Inflammation Versus Glucocorticoids as Purveyors of Pathology During Stress: Have We Reached the Tipping Point? (2008) (40)
- Interferon-alpha-induced inflammation is associated with reduced glucocorticoid negative feedback sensitivity and depression in patients with hepatitis C virus (2016) (39)
- Cytokines, p38 MAP Kinase and the Pathophysiology of Depression (2006) (39)
- Glucose and lipid-related biomarkers and the antidepressant response to infliximab in patients with treatment-resistant depression (2018) (38)
- Relationship of Clinical Symptoms and Substance Use in Schizophrenia Patients on Conventional Versus Atypical Antipsychotics (2003) (38)
- Promoter Polymorphisms of the Interferon-α Receptor Gene and Development of Interferon-Induced Depressive Symptoms in Patients with Chronic Hepatitis C: Preliminary Findings (2005) (38)
- Efficacy of risperidone versus olanzapine in patients with schizophrenia previously on chronic conventional antipsychotic therapy: a switch study. (2006) (38)
- Early activation of p38 mitogen activated protein kinase is associated with interferon-alpha-induced depression and fatigue (2011) (37)
- Depression, natural killer cell activity, and cortisol secretion (1991) (37)
- Depression and the Immune System (1991) (36)
- Pro-inflammatory cytokine-induced SAPK/MAPK and JAK/STAT in rheumatoid arthritis and the new anti-depression drugs (2008) (36)
- Two weeks of predatory stress induces anxiety-like behavior with co-morbid depressive-like behavior in adult male mice (2014) (34)
- A prospective study of quality of life in breast cancer patients undergoing radiation therapy (2016) (34)
- Stress, the immune system, and health and illness. (1993) (32)
- Gene signatures in peripheral blood immune cells related to insulin resistance and low tyrosine metabolism define a sub-type of depression with high CRP and anhedonia (2020) (31)
- Cytokines and sickness behavior: Implications for cancer care and control (2003) (31)
- Pro-inflammatory cytokine-induced SAPK/MAPK and JAK/STAT in rheumatoid arthritis and the new anti-depression drugs. (2008) (30)
- Association of T and non-T cell cytokines with anhedonia: Role of gender differences (2018) (27)
- Cytokines and HPA Axis Regulation (2003) (25)
- Associations among human papillomavirus, inflammation, and fatigue in patients with head and neck cancer (2018) (25)
- Activation of cAMP–protein kinase A abrogates STAT5-mediated inhibition of glucocorticoid receptor signaling by interferon-alpha (2011) (23)
- C‐reactive protein and its association with depression in patients receiving treatment for metastatic lung cancer (2018) (23)
- Gut Microbiome Associated with the Psychoneurological Symptom Cluster in Patients with Head and Neck Cancers (2020) (22)
- Inflammation in depression: is adiposity a cause? (2011) (22)
- Trial failures of anti-inflammatory drugs in depression. (2020) (22)
- Risk and Resilience: Animal Models Shed Light on the Pivotal Role of Inflammation in Individual Differences in Stress-Induced Depression (2015) (22)
- Brainstem dose is associated with patient-reported acute fatigue in head and neck cancer radiation therapy. (2017) (22)
- Immunologic influences on emotion regulation (2005) (22)
- The Microbiome and Complement Activation: A Mechanistic Model for Preterm Birth (2017) (21)
- Neuropsychiatric Adverse Effects of Interferon-α and Management (2005) (20)
- The Impact of Escitalopram on IL-2-Induced Neuroendocrine, Immune, and Behavioral Changes in Patients with Malignant Melanoma: Preliminary Findings (2013) (20)
- Identifying Immunophenotypes of Inflammation in Depression: Dismantling the Monolith (2020) (20)
- What’s CRP got to do with it? Tackling the complexities of the relationship between CRP and depression (2018) (20)
- CHAPTER 24 – Psychoneuroimmunology of Depressive Disorder: Mechanisms and Clinical Implications (2007) (20)
- High habitual dietary alpha-linolenic acid intake is associated with decreased plasma soluble interleukin-6 receptor concentrations in male twins. (2010) (20)
- Inflammation and treatment resistance in major depression: The perfect storm (2013) (19)
- Synthesis, fluorine-18 radiolabeling, and in vitro characterization of 1-iodophenyl-N-methyl-N-fluoroalkyl-3-isoquinoline carboxamide derivatives as potential PET radioligands for imaging peripheral benzodiazepine receptor. (2008) (19)
- Inflammation Effects on Glutamate as a Pathway to Neuroprogression in Mood Disorders. (2017) (18)
- Is C-reactive protein ready for prime time in the selection of antidepressant medications? (2017) (18)
- The role of the gut microbiome in cancer-related fatigue: pilot study on epigenetic mechanisms (2020) (18)
- Immune System Contributions to the Pathophysiology of Depression (2008) (17)
- Influence of desmethylimipramine on natural killer cell activity (1986) (17)
- An Intervention to Improve Physical Function and Caregiver Perceptions in Family Caregivers of Persons With Heart Failure (2020) (17)
- Pleiotropy of C-reactive protein gene polymorphisms with C-reactive protein levels and heart rate variability in healthy male twins. (2009) (17)
- Epigenetic age acceleration, fatigue, and inflammation in patients undergoing radiation therapy for head and neck cancer: A longitudinal study (2021) (17)
- Elucidating the consequences of chronic stress on immune regulation and behavior in rheumatoid arthritis (2008) (16)
- Differential regulation of NF-kB and IRF target genes as they relate to fatigue in patients with head and neck cancer (2018) (16)
- Ribavirin may be an important factor in IFN-induced neuropsychiatric effects. (2004) (16)
- Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications (2021) (15)
- Inflammatory markers are associated with psychomotor slowing in patients with schizophrenia compared to healthy controls (2020) (14)
- The immunology of stress and the impact of inflammation on the brain and behaviour (2021) (14)
- Posttraumatic stress disorder and breast cancer: Risk factors and the role of inflammation and endocrine function (2020) (14)
- Lymphocytic responses and the gradual hippocampal neuron loss following infection with lymphocytic choriomeningitis virus (LCMV) (1999) (14)
- Exercise and Cognitive Training as a Strategy to Improve Neurocognitive Outcomes in Heart Failure: A Pilot Study. (2019) (14)
- Natural killer cell activity in major depression: a prospective study of the in vivo effects of desmethylimipramine treatment (1995) (13)
- Use of high-resolution volumetric MR spectroscopic imaging in assessing treatment response of glioblastoma to an HDAC inhibitor. (2014) (12)
- Neurotherapeutic Implications of Brain-Immune Interactions (2014) (12)
- Three independent techniques localize expression of transcript afp-11 and its bioactive peptide products to the paired AVK neurons in Ascaris suum: in situ hybridization, immunocytochemistry, and single cell mass spectrometry. (2013) (11)
- On Redefining the Role of the Immune System in Psychiatric Disease (2006) (11)
- Tumor Mutation Burden and Depression in Lung Cancer: Association With Inflammation. (2019) (11)
- Pregnancy-Associated Plasma Protein-aa Regulates Photoreceptor Synaptic Development to Mediate Visually Guided Behavior (2018) (10)
- Chronically elevated depressive symptoms interact with acute increases in inflammation to predict worse neurocognition among people with HIV (2021) (10)
- Role of Inflammation in Psychiatric Disease (2015) (10)
- Depression-free after Interferon-α exposure indicates less incidence of depressive disorder: A longitudinal study in Taiwan (2020) (9)
- Association of epigenetic age acceleration with risk factors, survival, and quality of life in patients with head and neck cancer. (2021) (9)
- [Neuro-immune interactions in psychopathology with the example of interferon-alpha-induced depression]. (2003) (9)
- Neuroendocrine-Immune Interactions: Implications for Health and Behavior (2009) (9)
- Depression and inflammation among epidermal growth factor receptor (EGFR) mutant nonsmall cell lung cancer patients (2019) (9)
- Five Things to Know About Inflammation and Depression (2018) (9)
- Physical problem list accompanying the distress thermometer: Its associations with psychological symptoms and survival in patients with metastatic lung cancer (2020) (9)
- Inflammatory mechanisms contribute to microembolism-induced anxiety-like and depressive-like behaviors (2016) (9)
- Transcriptomic Signatures of Psychomotor Slowing in Peripheral Blood of Depressed Patients: Evidence for Immunometabolic Reprogramming (2021) (8)
- Brain–Immune System Interactions: Relevance to the Pathophysiology and Treatment of Neuropsychiatric Disorders (2009) (8)
- Pilot study of combined aerobic and resistance exercise on fatigue for patients with head and neck cancer: Inflammatory and epigenetic changes (2020) (8)
- Biochemical mechanisms of stress-induced impairment of rat T cell mitogenesis (1991) (8)
- Depression and Inflammation in Patients With Lung Cancer: A Comparative Analysis of Acute Phase Reactant Inflammatory Markers. (2020) (8)
- Adherence to the Mediterranean Diet Is Inversely Associated With Circulating Interleukin-6 Among Middle-Aged Men A Twin Study Epidemiology (2008) (7)
- The effects of roux en y gastric bypass surgery on neurobehavioral symptom domains associated with severe obesity (2019) (7)
- Pain Intensity and Pain Interference in Patients With Lung Cancer: A Pilot Study of Biopsychosocial Predictors (2015) (7)
- Biology of Depression and Cytokines in Cancer (2010) (7)
- Interleukin-1 Mediates Long-Term Hippocampal Dentate Granule Cell Loss Following Postnatal Viral Infection (2010) (7)
- Letter to the Editor Re: “An inflammatory review of glucocorticoids in the CNS” by Sorrells et al. Brain, Behavior and Immunity 21, 259–272, 2007 (2007) (7)
- Les interactions neuro-immunes en psychopathologie: l'exemple de la dépression sous interféron-alpha. (2003) (7)
- Prognostic implications of depression and inflammation in patients with metastatic lung cancer. (2020) (7)
- Activation of CNS Inflammatory Pathways by Interferon-alpha: Relationship to Monoamines and Depression (7)
- Anti-inflammatory agents as antidepressants: Truth or dare (2015) (6)
- Association Among Glucocorticoid Receptor Sensitivity, Fatigue, and Inflammation in Patients With Head and Neck Cancer (2020) (5)
- Cancer‐related inflammation and depressive symptoms: Systematic review and meta‐analysis (2022) (5)
- Kynurenines increase MRS metabolites in basal ganglia and decrease resting-state connectivity in frontostriatal reward circuitry in depression (2021) (5)
- Interactions Between the Hypothalamic‐Pituitary‐Adrenal Axis and Immune System During Viral Infection: Pathways for Environmental Effects on Disease Expression (2011) (5)
- Antidepressant treatment of cytokine-induced mood disorders (2002) (4)
- Neuroendocrine-Immune Interactions (2002) (4)
- Instruments for determining clinically relevant fatigue in breast cancer patients during radiotherapy (2019) (4)
- The interaction of lipids and inflammatory markers predict negative symptom severity in patients with schizophrenia (2021) (4)
- Full axillary lymph node dissection and increased breast epidermal thickness 1 year after radiation therapy for breast cancer (2019) (4)
- Plasma homocysteine and immune activation in patients with malignant melanoma undergoing treatment with IFN-α (2004) (4)
- Decreased basal ganglia activation in Chronic Fatigue Syndrome subjects is associated with increased fatigue (2012) (4)
- The Future of Psychoneuroimmunology: Promises and Challenges (2018) (4)
- Caregiver subjective and physiological markers of stress and patient heart failure severity in family care dyads (2021) (4)
- Haplotypes of Serotonin Transporter Gene Associated with Both Depressive Symptoms and Interleukin-6 in Middle-Aged Males : The Twins Heart Study (2009) (4)
- Exercise and Cognitive Training Intervention Improves Self-Care, Quality of Life and Functional Capacity in Persons With Heart Failure (2020) (3)
- What’s in a name? How about being listed in the “Psychiatry” category in Clarivate’s Journal Citation Index! (2019) (3)
- A network analysis of self‐reported psychoneurological symptoms in patients with head and neck cancer undergoing intensity‐modulated radiotherapy (2022) (3)
- Depression, Inflammation, and Cancer (2021) (3)
- Cancer Symptom Science: Depression in cancer: pathophysiology at the mind-body interface (2010) (3)
- Breast cancer patient reported outcomes, depression, and objective measures of breast cosmesis. (2020) (3)
- A Longitudinal Analysis of Inflammation and Depression in Patients With Metastatic Lung Cancer: Associations With Survival (2020) (2)
- Depressive symptoms and viral clearance: In response (2005) (2)
- Efficacy and Safety of Xanomeline, a M1/M4 Receptor Preferencing Agonist, Plus Trospium, a Peripheral Muscarinic Antagonist, in Schizophrenia: Phase 2 Clinical Trial Results (2020) (2)
- Treatment of Depression in Medical Illness (2005) (2)
- Early childhood adversity in adult patients with metastatic lung cancer: Cross-sectional analysis of symptom burden and inflammation (2020) (2)
- Paroxetine for the prevention of depression in patients undergoing treatment with interferon-α plus ribavirin for hepatitis C (2006) (2)
- Plasma homocysteine and immune activation in patients with malignant melanoma undergoing treatment with IFN-alpha. (2004) (1)
- Epigenetic Mechanisms of Inflammation and Fatigue in Patients With Cancer (2018) (1)
- A prospective study on behavioral symptoms' impact to the quality of life in patients with early-stage cancer receiving radiotherapy. (2013) (1)
- 92. Increased stress-induced plasma IL-6 responses in male depressed patients with increased early life stress: Role of catecholamines (2008) (1)
- Using proton MRSI to predict response to vorinostat treatment in recurrent GBM. (2012) (1)
- Patterns of antidepressant use in cancer patients (pts): An analysis from SOAPP (ECOG E2Z02: Symptom Outcomes and Practice Patterns). (2012) (1)
- Abstract MP074: Pathway Linking Depression & Inflammation: A 5-year Longitudinal Twin Difference Study (2017) (1)
- Platelet Function and Coagulation During and Following Heat Stress (2007) (1)
- SU63. Association Between Inflammatory Markers and Negative Symptoms in Individuals With Persistent Symptoms of Schizophrenia Treated With Clozapine (2017) (1)
- Remembering Bruce S. McEwen – A tribute from psychoneuroimmunology (2021) (1)
- Patterns of antidepressant use in patients with cancer: An analysis from SOAPP (E2Z02: Symptom Outcomes and Practice Patterns). (2012) (1)
- Racial disparities in depressive symptom prevalence and selective serotonin reuptake inhibitor (SSRI) utilization in cancer patients: An analysis from ECOG E2Z02: Symptom Outcomes and Practice Patterns (SOAPP). (2012) (1)
- T106. KARXT: A M1/M4 PREFERRING MUSCARINIC AGONIST FOR THE TREATMENT OF SCHIZOPHRENIA (2019) (1)
- Predictors of Breast Pain in Breast Cancer Patents One Year After Whole Breast Radiation Therapy (2017) (1)
- The association of fatigue with poor virologic response in patients receiving interferon-alpha plus ribavirin for the treatment of hepatitis C (2005) (1)
- CRS-207 vaccine plus chemotherapy as front-line treatment for subjects with malignant pleural mesothelioma (MPM). (2013) (0)
- EFFECTS OF PAROXETINE ON CYTOKINE RELEASE AND DEPRESSION INDUCED BY INTERFERON ALFA-2B (1999) (0)
- Les interactions neuro-immunes en psychopathologie : l'exemple de la dépression sous interféron-α : Cerveau et immunité (2003) (0)
- Development of a new green fluorescent protein-glucocorticoid receptor (GR) chimera to evaluate the effects of antidepressants and other steroid-independent activators of the GR (2000) (0)
- Abstract 2891: Chemokine-targeted models of human orthotopic colorectal cancer in immunocompetant mice (2015) (0)
- 2329 Associations between inflammatory markers and negative symptoms in individuals with schizophrenia: Converging evidence (2018) (0)
- #107 Indicators of innate immune system activity in humans increase with psychosocial stressor challenge: Major depressives vs. non-depressives (2005) (0)
- Plasma Metabolic Phenotypes of HPV-Associated versus Smoking-Associated Head and Neck Cancer and Patient Survival (2021) (0)
- IP4 regulates FasL-mediated T lymphocyte death via inhibition of Orai1 (115.1) (2012) (0)
- F236. Association of Baseline Tumor Necrosis Factor and the Development of Negative Symptoms in Individuals at Clinical High Risk for Psychosis (2018) (0)
- Abstract 2305: Decreased Heart Rate Variability, a Measure of Autonomic Dysfunction, is Associated with Higher Levels of Inflammation as Measured by IL-6 (2006) (0)
- Inflammation affects social experience: implications for mental health (2020) (0)
- Cellular and immunometabolic mechanisms of inflammation in depression: Preliminary findings from single cell RNA sequencing and a tribute to Bruce McEwen (2022) (0)
- Current Management of Depression in Cancer Patients (2002) (0)
- Neuropsychiatric effects of IFN-alpha: relevance to depression (2009) (0)
- Constitutive activation of the mammalian target of rapamycin complex 1 (mTORC1) is associated with skeletal muscle insulin resistance (2008) (0)
- #38 Immune, neuroendocrine, and behavioral response to interferon α in rhesus monkeys: A potential role for CRF (2005) (0)
- Inflammation and Depression (2012) (0)
- Abstract 3905: Genetic and Environmental Influences on Inflammatory Markers: A Study of Middle-Aged Male Twins (2006) (0)
- Burning down the house: reinventing drug discovery in psychiatry for the development of targeted therapies (2022) (0)
- Abstract LB-159: Using proton MRSI to predict response of Vorinostat treatment in recurrent GBM (2012) (0)
- Psychoneuroimmunology: Stress, Mental Disorders and Health (2002) (0)
- Abstract 18108: Effects of a Heart Failure Family Caregiver Intervention on Caregiver Strain and Outcomes (2014) (0)
- Effects of interferon (IFN) α on immune, neuroendocrine, and behavioral measures in rhesus monkeys: A potential role for CRF (2006) (0)
- Enhanced psychosocial stress-induced IL-6 responses are associated with attenuated stress-induced cortisol responses in patients with major depression and increased early life stress (2006) (0)
- 226. ‘Inflammaging' in Depression - Morphological, Metabolic and Behavioral Consequences (2019) (0)
- Full Axillary Lymph Node Dissection and Increased Breast Epidermal Thickness One Year After Radiation for Breast Cancer (2017) (0)
- The Authors’ Reply (2005) (0)
- Abstract 500: Neuropsychological symptoms in patients with head and neck cancer undergoing radiation therapy: A network analysis (2022) (0)
- F16. INFLAMMATORY MARKERS ARE ASSOCIATED WITH PSYCHOMOTOR SLOWING IN PATIENTS WITH SCHIZOPHRENIA COMPARED TO HEALTHY CONTROLS (2019) (0)
- Oral Scientific SessionsA Prospective Longitudinal Study of Radiation Therapy–Induced Skin Toxicity and Long-term Fatigue in Breast Cancer Patients (2017) (0)
- Prospective Longitudinal Study of Radiation-induced Cutaneous Toxicity in Breast Cancer Patients Undergoing Breast Conserving Therapy (2012) (0)
- Abstract SY31-04: Impact of cytokines on neurocircuits relevant to anxiety, depression, and fatigue in cancer patients (2012) (0)
- Transcriptomic Signatures of Inflammation and Metabolic Reprogramming in Peripheral Blood Immune Cells are Implicated in Psychomotor Retardation in Depression (2021) (0)
- IMRT-Induced Acute Fatigue in Patients with Head and Neck Cancer: A Prospective Study (2014) (0)
- Psychomotor slowing during interferon-alpha therapy is associated with self-reported fatigue levels (2006) (0)
- Perceived stress to predict for acute radiation-induced skin toxicity: The mind-body connection. (2013) (0)
- Implications of inflammation for neuropsychiatric disease: Contributions and consequences (2016) (0)
- Abstract P3-19-29: Polygenic risk scores predict toxicities in racially diverse breast cancer patients following radiotherapy (2022) (0)
- 111. The curcumin analog, UBS-109 decreases peripheral expression of LPS-induced inflammatory cytokines (2008) (0)
- The neurocircuitry of inflammation in depression: disrupted striatal connectivity and relationships with anxiety, anhedonia and psychomotor slowing (2014) (0)
- 345 Depression during IFN-ALFA plus ribavirin therapy: prevalence and prediction (2003) (0)
- The impact of compassion training on medical student well-being and immune function. (2016) (0)
- Cerebrospinal fluid and plasma interleukin-6 concentrations in combat veterans with PTSD (2000) (0)
- The influence of radiotherapy on sleep disturbances in breast cancer patients. (2014) (0)
- 7955 Subcortical Glutamate Increase Suggestive of Glial Toxicity in Depressed patients with High Inflammation (2013) (0)
- S176. Relationships Between Inflammatory Markers and Kynurenine Metabolites in Patients With Schizophrenia but Not Healthy Controls (2019) (0)
- The influence of childhood trauma on fatigue and depression in breast cancer patients during and after radiotherapy. (2014) (0)
- Abstract PO-033: Metabolic differences between human papillomavirus-related and smoking-related squamous cell carcinoma of the head and neck independently predict overall patient survival (2020) (0)
- hronic Interferon-Alpha Administration Disrupts leep Continuity and Depth in Patients with Hepatitis : Association with Fatigue, Motor Slowing, and ncreased Evening Cortisol (0)
- 52 Schizophrenia and substance abuse: Characteristics associated with the high rate of comorbidity (1997) (0)
- Increased Fatigue Is Associated With TNF and NFκB-Regulated Inflammatory Signaling in Patients With Head and Neck Cancer Receiving IMRT (2014) (0)
- High Inflammation and Metabolic Dysfunction are Associated With Slowed Startle Response Latency in Patients With Schizophrenia (2021) (0)
- Abstract 4095: Adherence to the Mediterranean Diet Decreases Systemic IL-6 Among Middle-aged Monozygotic Male Twins Free of Symptomatic Cardiovascular Diseases (2006) (0)
- P236. Immunometabolic Signatures in Monocytes Are Associated with Anhedonia in Depressed Patients with High Inflammation (2022) (0)
- Dr. Heim and Colleagues Reply (2002) (0)
- Abstract 4257: Predicting fatigue levels of head and neck cancer patients with gene expression using machine learning (2018) (0)
- Pretreatment with the antidepressant, paroxetine, attenuates development of sickness behavior during high dose interferon alpha therapy (2000) (0)
- #41 Do cytokines cause a depressive syndrome that is indistinguishable from major depression in medically healthy individuals? A comparative analysis of symptom dimensions (2005) (0)
- CNS Dose Is Not Associated With Treatment-Related Fatigue in Patients Undergoing Radiation Therapy for Head and Neck Cancer (2016) (0)
- Persistent Fatigue Is Associated With Persistent Peripheral Inflammation in Patients With Squamous Cell Carcinoma of the Head and Neck Cancer up to 3 Months Post-Intensity Modulated Radiation Therapy (2016) (0)
- Chapter 7 Stress and the immune system (2000) (0)
- Pituitary-adrenal responsiveness of adult survivors of childhood abuse in the CRF stimulation test (2000) (0)
- A Prospective Study of Cancer-related Fatigue in Women Undergoing Radiotherapy for Breast Cancer (2011) (0)
- 111 Magnetic Resonance Spectroscopic Imaging Measurement of Early Response to Vorinostat Treatment in Recurrent Glioblastoma. (2012) (0)
- Offi cial journal of the Chinese Pharmacological Society and Shanghai Institute of Materia Medica, Chinese Academy of Sciences (2006) (0)
- 153. Inflammation Effects on Motivation and Motor Activity: Dopamine as Mediator and Treatment Target (2018) (0)
- 154. Gender-Specific Association of IL-17 with Anhedonia in Depressed Outpatients: Findings From CO-MED Trial (2018) (0)
- A prospective longitudinal study of cancer-related fatigue in patients undergoing breast-conserving surgery and radiation with or without chemotherapy for breast cancer. (2012) (0)
- 141. From Inflammation to Anhedonia - Role of Glutamate, Regional Homogeneity and Network Dysfunction (2019) (0)
- 102. Inflammation Effects on Striatal Dopamine: Implications for Late Life Depression (2019) (0)
- P595. Tumor Necrosis Factor is Associated With Altered Activation in Ventral Striatum and Anterior Insula in Response to Reward and Effort in Patients With Schizophrenia (2022) (0)
- Complement Activation During Early Pregnancy and Clinical Predictors of Preterm Birth in African American Women (2019) (0)
- Fundamentals of Psychoneuroimmunology (2002) (0)
- Medulla Dose is Positively Associated with Sensation of Thirst & Midbrain Dose is Inversely Associated with Pain: Prospectively-Collected Patient-Reported Toxicities and Brainstem Dose in Head and Neck Cancer Radiation Therapy (2018) (0)
- Trafficking of natural killer cells during exposure to psychological stress: Role of the adhesion molecule, L-selectin (2006) (0)
- Changes in Physical Activity and Psychological Factors Among Breast Cancer Survivors Enrolled in a YMCA Program (2015) (0)
- Mini Quiz: Inflammation and Psychiatric Disorders (2018) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Andrew H. Miller?
Andrew H. Miller is affiliated with the following schools: